Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Alcaide

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2026
Detecting ctDNA Using Personalized Structural Variants to Forecast Recurrence in Localized Soft Tissue SarcomaChangsu L Park, Elizabeth G Demicco, Karen Howarth, et al.
Scientific Reports|September 7, 2017
Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baitsMiguel Alcaide, Stephen Yu, Jordan Davidson, et al.
Biotechniques|February 13, 2019
A high-throughput protocol for isolating cell-free circulating tumor DNA from peripheral bloodPawan K Pandoh, Richard D Corbett, Helen McDonald, et al.
British Journal of Haematology|September 13, 2024
A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphomaJohn Kuruvilla, Christopher Rushton, Diego Villa, et al.
EMBO Molecular Medicine|May 26, 2026
NeoCircle: pre- and post-operative circulating tumor DNA dynamics predicts survival in neoadjuvant-treated early breast cancerAnthony M George, Yilun Chen, Sergii Gladchuk, et al.
Blood|May 12, 2016
Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphomaSarit E Assouline, Torsten Holm Nielsen, Stephen Yu, et al.
Leukemia & Lymphoma|April 5, 2018
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana LinfomiFrancesco Zaja, Flavia Salvi, Maura Rossi, et al.
Blood|March 12, 2020
Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencingPrasath Pararajalingam, Krysta M Coyle, Sarah E Arthur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2025
Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast CancerMitchell J Elliott, Karen Howarth, Sasha Main, et al.
Blood Advances|June 27, 2020
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphomaChristopher K Rushton, Sarah E Arthur, Miguel Alcaide, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2026
Detecting ctDNA Using Personalized Structural Variants to Forecast Recurrence in Localized Soft Tissue SarcomaChangsu L Park, Elizabeth G Demicco, Karen Howarth, et al.
Scientific Reports|September 7, 2017
Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baitsMiguel Alcaide, Stephen Yu, Jordan Davidson, et al.
Biotechniques|February 13, 2019
A high-throughput protocol for isolating cell-free circulating tumor DNA from peripheral bloodPawan K Pandoh, Richard D Corbett, Helen McDonald, et al.
British Journal of Haematology|September 13, 2024
A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphomaJohn Kuruvilla, Christopher Rushton, Diego Villa, et al.
EMBO Molecular Medicine|May 26, 2026
NeoCircle: pre- and post-operative circulating tumor DNA dynamics predicts survival in neoadjuvant-treated early breast cancerAnthony M George, Yilun Chen, Sergii Gladchuk, et al.
Blood|May 12, 2016
Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphomaSarit E Assouline, Torsten Holm Nielsen, Stephen Yu, et al.
Leukemia & Lymphoma|April 5, 2018
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana LinfomiFrancesco Zaja, Flavia Salvi, Maura Rossi, et al.
Blood|March 12, 2020
Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencingPrasath Pararajalingam, Krysta M Coyle, Sarah E Arthur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2025
Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast CancerMitchell J Elliott, Karen Howarth, Sasha Main, et al.
Blood Advances|June 27, 2020
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphomaChristopher K Rushton, Sarah E Arthur, Miguel Alcaide, et al.
Pageof 6